Ryan Kole

Ryan Kole

Company: Beyond Barriers Therapeutics

Job title: Chief Executive Officer

Seminars:

Why Intranasal Delivery for Effective Targeting to the Brain? 1:30 pm

Tailoring particle size to ensure efficient brain-targeted drug delivery, enhancing therapeutic efficacy Overcoming challenges related to drug expulsion, increasing retention in the brain by effectively managing P-glycoprotein efflux and nanocarrier transport Reducing impeding metabolic activity with enzyme inhibitors, enhancers and excipients to decrease frequency of administrationRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.